R J BIO-TECH | HIMALYA INT. | R J BIO-TECH/ HIMALYA INT. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | - | -5.1 | - | View Chart |
P/BV | x | - | 1.1 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
R J BIO-TECH HIMALYA INT. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
R J BIO-TECH Mar-22 |
HIMALYA INT. Mar-23 |
R J BIO-TECH/ HIMALYA INT. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 12 | 29 | 41.2% | |
Low | Rs | 5 | 16 | 31.2% | |
Sales per share (Unadj.) | Rs | 14.7 | 11.8 | 124.2% | |
Earnings per share (Unadj.) | Rs | -4.3 | -4.2 | 102.3% | |
Cash flow per share (Unadj.) | Rs | -4.2 | -3.0 | 140.0% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -53.2 | 23.0 | -231.2% | |
Shares outstanding (eoy) | m | 9.47 | 57.87 | 16.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 1.9 | 30.3% | |
Avg P/E ratio | x | -2.0 | -5.4 | 36.7% | |
P/CF ratio (eoy) | x | -2.0 | -7.6 | 26.8% | |
Price / Book Value ratio | x | -0.2 | 1.0 | -16.3% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 81 | 1,314 | 6.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 6 | 42 | 14.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 139 | 684 | 20.3% | |
Other income | Rs m | 7 | 291 | 2.3% | |
Total revenues | Rs m | 146 | 975 | 14.9% | |
Gross profit | Rs m | 12 | -467 | -2.5% | |
Depreciation | Rs m | 1 | 68 | 1.0% | |
Interest | Rs m | 58 | 3 | 1,764.2% | |
Profit before tax | Rs m | -40 | -247 | 16.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | -5 | -0.0% | |
Profit after tax | Rs m | -40 | -242 | 16.7% | |
Gross profit margin | % | 8.4 | -68.3 | -12.3% | |
Effective tax rate | % | 0 | 2.1 | -0.0% | |
Net profit margin | % | -29.1 | -35.4 | 82.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 3 | 405 | 0.7% | |
Current liabilities | Rs m | 484 | 803 | 60.2% | |
Net working cap to sales | % | -345.9 | -58.1 | 595.0% | |
Current ratio | x | 0 | 0.5 | 1.2% | |
Inventory Days | Days | 3 | 308 | 0.8% | |
Debtors Days | Days | 7,265,677 | 1,637 | 443,891.3% | |
Net fixed assets | Rs m | 16 | 1,825 | 0.9% | |
Share capital | Rs m | 95 | 579 | 16.4% | |
"Free" reserves | Rs m | -598 | 752 | -79.6% | |
Net worth | Rs m | -503 | 1,331 | -37.8% | |
Long term debt | Rs m | 33 | 0 | - | |
Total assets | Rs m | 19 | 2,230 | 0.9% | |
Interest coverage | x | 0.3 | -73.9 | -0.4% | |
Debt to equity ratio | x | -0.1 | 0 | - | |
Sales to assets ratio | x | 7.2 | 0.3 | 2,362.5% | |
Return on assets | % | 92.4 | -10.7 | -863.5% | |
Return on equity | % | 8.0 | -18.2 | -44.2% | |
Return on capital | % | -3.8 | -18.3 | 20.6% | |
Exports to sales | % | 0 | 49.4 | 0.0% | |
Imports to sales | % | 2.5 | 0 | - | |
Exports (fob) | Rs m | NA | 338 | 0.0% | |
Imports (cif) | Rs m | 4 | NA | - | |
Fx inflow | Rs m | 0 | 338 | 0.0% | |
Fx outflow | Rs m | 4 | 0 | - | |
Net fx | Rs m | -4 | 338 | -1.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -47 | 65 | -72.3% | |
From Investments | Rs m | NA | -28 | -0.0% | |
From Financial Activity | Rs m | 47 | -39 | -119.6% | |
Net Cashflow | Rs m | 0 | -2 | 20.5% |
Indian Promoters | % | 60.3 | 42.1 | 143.2% | |
Foreign collaborators | % | 0.0 | 8.4 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 39.7 | 49.5 | 80.2% | |
Shareholders | 245 | 30,854 | 0.8% | ||
Pledged promoter(s) holding | % | 0.0 | 26.7 | - |
Compare R J BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | R J BIO-TECH | HIMALYA INT. | S&P BSE FMCG |
---|---|---|---|
1-Day | 0.59% | -1.85% | 0.11% |
1-Month | 1.48% | 8.66% | 1.53% |
1-Year | -26.39% | 5.27% | 14.09% |
3-Year CAGR | -24.59% | 33.50% | 15.86% |
5-Year CAGR | -25.99% | 25.57% | 10.81% |
* Compound Annual Growth Rate
Here are more details on the R J BIO-TECH share price and the HIMALYA INT. share price.
Moving on to shareholding structures...
The promoters of R J BIO-TECH hold a 60.3% stake in the company. In case of HIMALYA INT. the stake stands at 50.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of R J BIO-TECH and the shareholding pattern of HIMALYA INT..
Finally, a word on dividends...
In the most recent financial year, R J BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
HIMALYA INT. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of R J BIO-TECH, and the dividend history of HIMALYA INT..
For a sector overview, read our fmcg sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.